Not sure I see why it will be fast tracked. Regeneron is way ahead and has mAB. Granted, different technology but does ENZC have enough to be a differentiator that would result in fast tracking? Although I’m along on ENZC I don’t see it.
Anyone else have any reasons to support otherwise?
I'd put a 1-2 yr minimum on it, from the beginning of trials, which I believe won't begin for several months. I'd guess well into 2023 before we know anything regarding the effectiveness, commercial viability and safety, should the process be completed.
As fast as this bio virus mutates its not going to be long before every health official will be throwing everything including the kitchen sink to try to stop it. It’s going to keep spreading and mutating until some company like ENZC and others find the right combination to stop it. Years of clinical trials is not fast enough so we should expect to see a lot of Emergency Use Authorization fast tracked to save as many lives as they can.
Agreed. It hasn’t been years and these products are out. Even if they are repurposed they would have to go through some sort of process in order to be used on COVID